Therefore, this study aims to evaluate the clinical characteristics and prognostic significance of serum LDH levels in patients with anti-MDA5+ DM, to help achieve accurate assessment of the patient’s condition and improve the prognosis of anti-MDA5+ DM patients. This evidence concerns the gene IFIH1 and dermatomyositis.